Infant botulism: A case series and review of the literature

Journal of Emergency Medicine

Volumn 10, Issue 6, 1992, Pages 713-718

  Schmidt, Robert D ^a   Schmidt, Tyler W ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

constipation; hypotonia; infant botulism; respiratory insufficiency; weakness

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTITOXIN; BOTULINUM TOXIN; CEPHALOSPORIN; HYPERIMMUNE GLOBULIN;

ARTICLE; BOTULISM; CASE REPORT; CONSERVATIVE TREATMENT; CONSTIPATION; DIFFERENTIAL DIAGNOSIS; EMERGENCY MEDICINE; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; PROGNOSIS; RESPIRATORY FAILURE;

ACUTE DISEASE; BOTULISM; CASE REPORT; DIAGNOSIS, DIFFERENTIAL; EMERGENCIES; FEMALE; HUMAN; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; RESPIRATORY INSUFFICIENCY; RISK FACTORS;

EID: 0026472586     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/0736-4679(92)90530-7     Document Type: Article

References (40)

1. Infant botulism in 1931: discovery of a misclassified case
2. Coproexamination for botulinal toxin and Clostridium botulinum
3. Infant botulism
4. The intestinal flora and infant botulism
5. The rat as an animal model for infant botulism
6. Intraintestinal toxin in infant mice challenged intragastrically with C. botulinum spores
7. Intestinal infection and toxin production by Clostridium botulinum as one of sudden infant death syndrome
8. Absorption of botulinal toxin from the gastrointestinal tract
9. Botulism
10. Epidemiologic study of infant botulism in Pennsylvania: report of the infant botulism study group
11. Infant botulism
12. Risk factors for infant botulism in the United States
13. Infant botulism: clinical spectrum and epidemiology
14. Infant botulism-Massachusetts
15. Epidemiologic characteristics of botulism in the United States, 1950–1979
16. Protective role of human milk against sudden infant death from infant botulism
17. Honey and other environmental risk factors for infant botulism
18. Number of clostridium botulinum spores in honey
19. Isolation of Clostridium botulinum from honey
20. Incidence and origin of clostridium botulinum spores in honey
21. Honey exposure and infant botulism
22. Infant botulism and the honey connection
23. Diagnosis and management of infant botulism
24. Clinical, laboratory and environmental features of infant botulism in southeastern Pennsylvania
25. Infant botulism: case report and clinical update
26. The clinical spectrum of infant botulism
27. Continuous microbiological study of 70 sudden and unexpected infant deaths: toxigenic intestinal clostridium botulinum infection in 9 cases of sudden infant death syndrome
28. The sudden infant death syndrome and infant botulism
29. Infant botulism: epidemiological, clinical, and laboratory aspects
30. Quantities of clostridium botulinum organisms and toxin in the feces and presence of clostridium botulinum toxin in the serum of an infant with botulism
31. Infant botulism: identification of Clostridium botulinum and its toxin in feces
32. Syndrome of botulism in infancy: clinical and electrophysiologic study
33. Clinical electrophysiology of infantile botulism
34. Infant botulism: a review of 12 years' experience at the Children's Hospital of Philadelphia
35. The neuromuscular blocking action of gentamicin
36. Effect of various antibiotics on neuromuscular transmission
37. Neuromuscular blocking activity of gentamicin in cats and mice
38. Potentiation of clostridium botulinum toxin by aminoglycoside antibiotics: clinical and laboratory observations
39. Clinical trial of botulism immune globulin for infant botulism